Recombinant human chorionic gonadotropin can promote ovulation, luteal development, testicular secretion of testosterone, test testicular function, used in the treatment of female infertility, pubertal cryptorchidism, miscarriage, male infertility and other diseases.
1. Female infertility: It can promote the secretion of pituitary gonadotropin, resulting in anovulatory infertility.
2. Pubertal cryptorchidism: it can be used as a diagnostic and therapeutic medicine.
3. Miscarriage: it can be used for preeclampsia and habitual miscarriage.
4. Male infertility: used for infertility with hypopituitarism, also combined with testosterone to treat infertility with hypogonadotropic hypogonadotropic hypogonadotropic hypogonadotropic hypogonadotropic hypogonadism.
The common adverse effects of this drug include ovarian enlargement, premature labor, and neonatal immaturity.
It is contraindicated in the case of pituitary tumors, prostate cancer, precocious puberty, ovarian cysts and allergy to this drug.
The use of this drug must follow the doctor’s instructions, not blindly use the drug on their own, so as not to cause adverse consequences.